HAMILTON, ON, April 5, 2023 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, wishes to invite shareholders and other interested parties to attend a webinar on Wednesday, April 12 th , 2023 at 9:00am PDT / 12:00pm EDT, at which the Company will provide an update on operations and review the outlook for the remainder 2023.
“Reliq will be filing its financials for the quarter ending March 31 st , 2023 next month,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “In the interim the Company will be hosting a webinar on April 12 th to provide an update on the impressive progress it has made to date on improving adherence and accelerating collections. As previously disclosed, the Company is on track to have taken over responsibility for patient adherence for all clients by the end of this fiscal year (June 30th, 2023). Reliq is also on track to be caught up on collections for Current Receivables by the end of June, which translates to a significant influx of cash for the Company over the first half of calendar year 2023.”
Webinar Login Information:
Date: April 12 th , 2023
Time: 9:00am PDT / 12:00pm EDT
URL: www.reliqhealth.com/webinar
For those who are not able to attend the webinar, a recording will be available on the Company’s website (www.reliqhealth.com) shortly after the webinar concludes.
Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
